What Is Schistosoma Haematobium and What Does It Cause?

Schistosoma haematobium is a parasitic flatworm that lives in human blood vessels surrounding the bladder and causes urogenital schistosomiasis, a chronic disease whose hallmark is blood in the urine. The infection has plagued humans for millennia, with eggs and parasite antigens identified in Egyptian mummies dating to around 3200 B.C.¹ Today it remains one of the most widespread neglected tropical diseases, concentrated in sub-Saharan Africa and parts of the Middle East. But the damage it causes extends well beyond bloody urine, reaching into the reproductive tract, the kidneys, and even the risk of bladder cancer.

How People Get Infected

You pick up S. haematobium by wading, swimming, or bathing in freshwater that contains the parasite’s free-swimming larval form, called cercariae. These larvae are released by specific freshwater snails in the genus Bulinus, which serve as the parasite’s obligatory intermediate host. Without those snails, the worm’s lifecycle cannot continue. Several Bulinus species carry the infection, but B. truncatus consistently shows the highest transmission potential, followed by B. globosus and B. senegalensis.²

Transmission is not uniform across the year. Cercarial emergence follows seasonal patterns, peaking during rainy seasons when snail populations flourish. In Tanzania, cercarial shedding from Bulinus snails was significantly higher during the rains, and snail abundance itself was tied to water temperature and salinity.³ In Nigeria’s Ase River catchment, over 40% of Bulinus snails collected were infected with S. haematobium, and infectivity peaked in the dry months of January and February.² The upshot is that risk depends heavily on local ecology, season, and the specific water body you are in.

Irrigation projects and dam construction have historically amplified the problem. Agricultural development that introduces standing or slow-moving fresh water creates ideal breeding habitat for Bulinus snails, expanding transmission into areas that were previously free of the disease.⁴

What Happens After the Larvae Enter Your Skin

Once cercariae contact your skin, they burrow into the epidermis within minutes. During the first day, roughly 90% of the young parasites are still in the outermost skin layer. Most reach the deeper dermis by about 48 hours and approach the blood vessels around 72 hours after initial contact.⁵ From there, the immature worms travel through the bloodstream to the liver, where they mature into adults and pair up. The adult worm pairs then migrate to the veins surrounding the urinary bladder, where they can live for years, sometimes decades.

The real damage comes not from the worms themselves but from the eggs they produce. Female worms deposit hundreds of eggs daily, and many of these eggs get trapped in the bladder wall and surrounding tissues. Your immune system mounts an intense inflammatory response to these eggs, building granulomas around each one. This immune reaction is driven by a Type 2 inflammatory response, characterized by high levels of specific immune signaling molecules and the recruitment of eosinophils, a type of white blood cell.⁶ Over weeks, dense collagen is deposited within and around these granulomas, and total collagen content in the bladder increases markedly. The result is thickening, scarring, and functional impairment of the bladder wall.

Early Warning Signs

In the early stages, infection can look like many other tropical illnesses. A study that tracked preschool-age children in Zimbabwe for early signs of S. haematobium found that children who went on to test positive had, at prior visits, dramatically higher odds of having an itchy rash, fever, abdominal pain, facial or body swelling, and pallor compared to children who stayed negative.⁷ Mild anemia was present in about one in six of the children who were becoming infected. Because these symptoms overlap with malaria, common viral infections, and allergic reactions, early schistosomiasis often gets missed in settings where it co-circulates with other diseases.

The classic symptom that eventually raises the alarm is hematuria, visible blood in the urine. In endemic communities, this is so common among school-age children that it has historically been normalized, sometimes even mistaken by children for a sign of puberty.

Chronic Bladder and Kidney Damage

Left untreated for years, the cycle of egg deposition and granuloma formation produces progressive fibrosis and calcification of the bladder wall. On imaging, this can appear as an eggshell-like pattern of calcium deposits lining the bladder, a finding virtually diagnostic of chronic S. haematobium infection.⁸ Coarse calcification, fibrosis, and strictures are signs of late-stage disease, and the bladder is typically the most severely affected organ.⁹

The trouble does not stop at the bladder. Scarring can obstruct the ureters, the tubes that carry urine from the kidneys to the bladder. When urine backs up, both kidneys swell with fluid, a condition called bilateral hydronephrosis. If this goes unrecognized, it leads to progressive kidney failure. Case reports describe patients who present late with end-stage renal failure requiring long-term dialysis and a place on a transplant waiting list, all traced back to chronic schistosomiasis.¹⁰ Even after successful drug treatment to kill the worms, established fibrosis and calcification are often irreversible, meaning patients may remain at risk for complications like ureteral obstruction and bladder malignancy for years afterward.⁸

The Link to Bladder Cancer

The International Agency for Research on Cancer classifies S. haematobium as a Group 1 carcinogen, meaning there is sufficient evidence that it causes cancer in humans. Specifically, chronic infection predisposes people to squamous cell carcinoma of the bladder, a type of cancer that is otherwise uncommon in the general population.⁹ The mechanism is thought to be mainly indirect. Eggs lodged in the bladder wall provoke chronic inflammation, which releases growth factors and other substances that promote malignant transformation. The persistent inflammation also disrupts local immune surveillance, allowing bacterial and viral co-infections that further push the tissue toward cancer.¹¹

More recent computational research has begun to identify specific egg-derived proteins that may contribute. One protein appears capable of binding to a growth receptor involved in tissue overgrowth, while another may bind to and disable p53, a key tumor-suppressor protein that normally prevents cells from becoming cancerous.¹² These are early-stage findings from modeling studies, but they point toward specific molecular targets that could eventually help explain why this particular parasite is so strongly linked to cancer.

Genital Schistosomiasis and Its Consequences

S. haematobium eggs do not confine themselves to the bladder. They frequently lodge in the reproductive tract of both women and men, a dimension of the disease that has been underrecognized for decades.

In women, the condition is known as female genital schistosomiasis (FGS). Eggs deposited in the cervix, vagina, and vulva trigger granuloma formation and fibrosis, damaging the genital mucosa.¹³ A study of women in rural Malawi found S. haematobium eggs in the genital tissue of about two-thirds of those examined, and the size of genital lesions correlated with the density of eggs in the tissue. Infertility was significantly more common in women with FGS, and the social consequences were stark: husbands of infertile women with FGS were more likely to have children with other women, and divorced women disproportionately had FGS.¹⁴

In men, the seminal vesicles and prostate are frequently affected. Egg-induced inflammation in these organs can lead to sperm damage and reduced seminal fluid.¹⁵ Male genital schistosomiasis likely contributes to subfertility in endemic areas, though it has received even less research attention than FGS.

FGS and the Increased Risk of HIV

One of the most consequential findings about female genital schistosomiasis is its association with HIV acquisition. FGS creates friable, damaged mucosal surfaces in the cervix and vagina, which mirrors the way genital ulcer disease increases HIV susceptibility. A systematic review and meta-analysis concluded that girls and women with schistosomiasis may face higher odds of HIV infection, with the association comparable in magnitude to that seen with genital ulcers.¹⁶

The numbers from individual studies are sobering. In a study in rural Zimbabwe, 41% of women with laboratory-confirmed genital schistosomiasis were HIV-positive, compared with 26% of those without genital involvement. After adjusting for other risk factors, genital schistosomiasis remained independently associated with HIV, with roughly a threefold increase in odds.¹⁷ A separate study in Tanzania found that women with urogenital schistosomiasis had about four times the odds of being HIV-infected compared with uninfected women.¹⁸ Given that both diseases are concentrated in the same regions of sub-Saharan Africa, treating schistosomiasis in young girls could, in theory, serve as a form of HIV prevention.

Effects on Children

Children bear a disproportionate share of the burden. School-age kids in endemic areas are the most heavily infected age group, often acquiring the parasite through daily water contact during play, bathing, or household chores. A study in a Kenyan community found that S. haematobium infection was a significant independent risk factor for anemia in both boys and girls. In boys, it also contributed to wasting and stunting, especially in the context of co-infections with malaria and other parasites. In girls, heavy infection was particularly linked to anemia.¹⁹ The combination of chronic blood loss in urine, inflammatory diversion of iron, and reduced appetite creates a cycle that stunts growth and undermines schooling.

How It Is Diagnosed

The traditional gold-standard diagnostic method is simply looking for parasite eggs in a urine sample collected around midday, when egg excretion peaks. A urine sample is filtered, and any eggs caught on the filter are counted under a microscope. The problem is that this method misses people with light infections who shed few eggs on any given day.

Reagent test strips that detect blood or protein in urine offer a quicker alternative. A large systematic review found that haematuria strips had about 85% sensitivity and 96% specificity for S. haematobium infection, while proteinuria strips were slightly less sensitive at about 73%.²⁰ These strips are cheap and fast, making them useful for community-level screening, but their sensitivity drops in people with light infections. One study found that strip sensitivity was over 90% in children with heavy infections but only about 56% in those with light infections.²¹ That matters because missing light infections allows ongoing transmission and chronic damage.

DNA-based testing offers better sensitivity. Researchers have shown that filtering urine onto paper and then testing the paper for parasite-specific DNA can detect infections that egg microscopy misses. In one comparison, DNA detection picked up positive samples among people whose urine showed no visible eggs, suggesting it catches low-level and cryptic infections that other methods overlook.²² The main barrier to wider use is cost and the need for laboratory equipment, which limits deployment in the rural settings where the disease is most common.

Treatment with Praziquantel

Praziquantel is the only drug currently used to treat all forms of schistosomiasis, and it has been the backbone of control programs for decades. A standard single dose is effective against adult worms, though it has limited activity against juvenile worms that have not yet matured. This is a meaningful gap, because immature worms can survive treatment and go on producing eggs once they grow up.

A trial in which patients received three monthly doses at 60 mg/kg achieved a cure rate of about 96%, with egg counts dropping sharply after the second dose.²³ That same study noted an initial spike in egg counts before the second dose, consistent with the idea that a single round leaves juvenile worms alive to produce more eggs. In children in Niger, two closely spaced doses also produced high cure rates and substantial reductions in egg output.²⁴ The drug is generally safe, though liver enzymes and kidney filtration rates can temporarily shift after the first dose before returning to normal with subsequent treatment.²³

A critical limitation is that praziquantel does not prevent reinfection. In endemic areas, children treated during mass drug administration campaigns can be reinfected within months simply by returning to the same water sources. And the drug’s inability to kill juvenile worms has raised concerns that prolonged, widespread use could eventually select for drug-resistant parasites.²⁵

Controlling the Snails

Because the parasite’s lifecycle depends entirely on Bulinus snails, killing those snails is a logical complement to treating infected people. The main chemical used is niclosamide, a molluscicide that has been in use for decades. The WHO promotes snail control as part of a comprehensive schistosomiasis elimination strategy that also includes drug treatment, clean water supply, improved sanitation, and behavior change.²⁶

In practice, snail control is frustratingly imperfect. A three-year intervention study on Pemba Island in Tanzania found that niclosamide application reduced or eliminated Bulinus in over half of treated water bodies in the first year. But a quarter of water bodies showed a pattern of recurring snail presence after treatment.²⁷ Snails repopulate from upstream sources, from eggs that survive in sediment, or from tributaries that were not treated. This means mollusciciding needs to be repeated regularly and combined with other strategies to have a lasting effect.

When Schistosomiasis Shows Up Where You Do Not Expect It

S. haematobium is overwhelmingly an African disease, but it is not confined there. One of the most striking recent episodes was an outbreak in Corsica, the French Mediterranean island. In 2013, swimmers in the Cavu River, a popular tourist destination in southern Corsica, began turning up with urogenital schistosomiasis, a disease that had never been reported on the island. A 12-year-old boy in Germany was diagnosed in early 2014 after swimming there months earlier.²⁸

By the time French authorities had finished investigating, they had documented over 100 confirmed cases from the 2013 swimming season alone, with a model-estimated total of roughly 340 infections. There was also evidence of small-scale transmission continuing in 2015.²⁹ The Cavu River was already home to Bulinus truncatus snails, which can transmit schistosomes. Molecular analysis showed the parasites had been imported by travelers infected in West Africa, likely Senegal. Adding another wrinkle, the parasites involved were hybrids between S. haematobium and S. bovis, a cattle schistosome, which may have enhanced their ability to colonize a new environment.³⁰ The Corsica outbreak demonstrated that any region with compatible snail hosts and enough visiting travelers from endemic countries is potentially at risk.

Why Some People Get Sicker Than Others

Not everyone infected with S. haematobium develops the same severity of disease. Part of this comes down to infection intensity, how many worms you harbor and how many eggs are deposited in your tissues. But host genetics also play a role. Variations in immune-related genes help explain why some people develop severe bladder pathology while others with similar egg burdens do not.

Research has identified specific genetic variants in the TNF-alpha gene, which codes for a key inflammation-signaling molecule, that are associated with higher egg counts and more severe disease. In one study, carriers of a particular variant at one TNF-alpha position had roughly five times the odds of developing more severe symptoms compared with people carrying the common version of the gene.³¹ Separately, polymorphisms in detoxification genes called glutathione-S-transferases have been linked to elevated risk of bladder pathology in infected individuals. People carrying certain variants of these genes had roughly four times the odds of developing bladder complications.³² These findings are still early-stage and come from relatively small studies, but they point toward a future where genetic screening could help identify people at highest risk of complications.

The Vaccine Question

Praziquantel’s limitations, especially its inability to prevent reinfection and its lack of activity against juvenile worms, have driven decades of effort toward a schistosomiasis vaccine. The idea is appealing: a vaccine that even partially reduced worm burdens could dramatically cut egg production and slow transmission across entire communities. Several candidate vaccines have been tested in animal models and early human trials, but none has yet reached widespread use.³³ The challenge is that schistosomes have evolved sophisticated mechanisms to evade the human immune system, making it difficult to find an antigen that triggers a strong, lasting protective response. Progress has been slow but research continues, with the understanding that a vaccine would complement rather than replace drug treatment and snail control as part of an integrated elimination strategy.²⁵

The Economics of a Neglected Disease

Schistosomiasis is both a consequence and a driver of poverty. Communities reliant on farming, fishing, and irrigation are exposed most, and the chronic disease burden feeds back into lost productivity. A rigorous economic analysis found that schistosomiasis measurably reduces agricultural production in affected areas, creating a cycle where the disease impoverishes the people least able to invest in clean water infrastructure or seek medical care.³⁴ Children who are chronically anemic and stunted do worse in school, earning less over their lifetimes. Women whose fertility is impaired face social marginalization. The damage compounds across generations, and the communities most affected are the ones with the fewest resources to break the cycle.